NASDAQ:OFIX

Orthofix Medical (OFIX) Stock Forecast, Price & News

$12.40

-0.29 (-2.29%)

(As of 09/26/2023 ET)

Compare

Today's Range: $12.38
▼
$12.78
50-Day Range: $12.40
▼
$21.36
52-Week Range: $12.26
▼
$23.19

Volume: 585,511 shs
Average Volume: 724,965 shs
Market Capitalization: $455.58 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $16.00

Orthofix Medical MarketRank™ Forecast

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 29.0% Upside
$16.00 Price Target
Short Interest: Healthy
1.76% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.41
Based on 6 Articles This Week
Insider Trading: Acquiring Shares
$101,025 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($0.66) to ($0.43) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

289th out of 963 stocks

Surgical & Medical Instruments Industry

35th out of 98 stocks

3.0

Analyst's Opinion

Consensus Rating
Orthofix Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $16.00, Orthofix Medical has a forecasted upside of 29.0% from its current price of $12.40.
Amount of Analyst Coverage
Orthofix Medical has only been the subject of 2 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
1.76% of the outstanding shares of Orthofix Medical have been sold short.
Short Interest Ratio / Days to Cover
Orthofix Medical has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Orthofix Medical has recently decreased by 5.96%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Orthofix Medical does not currently pay a dividend.
Dividend Growth
Orthofix Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OFIX.

0.9

News and Social Media Coverage

News Sentiment
Orthofix Medical has a news sentiment score of -0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Orthofix Medical this week, compared to 4 articles on an average week.
Search Interest
Only 2 people have searched for OFIX on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Orthofix Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $101,025.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 4.70% of the stock of Orthofix Medical is held by insiders.
Percentage Held by Institutions
89.76% of the stock of Orthofix Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Orthofix Medical are expected to grow in the coming year, from ($0.66) to ($0.43) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Orthofix Medical is -3.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Orthofix Medical is -3.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Orthofix Medical has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Orthofix Medical (NASDAQ:OFIX) Stock

Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone growth stimulator devices for enhance of bone fusion including adjunctive and noninvasive treatment of cervical and lumbar spine as well as a therapeutic treatment for non-spine; the spinal implants products designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and the biological products, such as regenerative products and tissue forms which allow physicians to treat a variety of spinal and orthopedic conditions. Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine, which design, develop, and market the orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. It sells its products through distributors, sales representatives, hospitals, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.

OFIX Price History

30 days | 90 days | 365 days | Advanced Chart

OFIX Stock News Headlines

September 26, 2023 | tmcnet.com

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Orthofix Medical Inc. Investors to Inquire About Securities Class Action Investigation - OFIX

September 26, 2023 | finance.yahoo.com

Implantable Medical Devices Market to grow by USD 51.1 billion from 2022-2027 | North America to account for 45% of market growth - Technavio

September 27, 2023 | Edge On The Street (Ad)

Is Gold Really Boring?

Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.

September 22, 2023 | markets.businessinsider.com

Orthofix Ongoing Investor Alert

September 21, 2023 | finance.yahoo.com

Orthofix (OFIX) Unveils Gemini System, Advances in Trauma Wing

September 20, 2023 | finance.yahoo.com

Orthofix Announces First Patient Procedures and Full Commercial Launch of the Galaxy Fixation Gemini System and Expanded Sterile Kit Offerings for Orthopedic Trauma Procedures

September 19, 2023 | markets.businessinsider.com

Orthofix Shareholder Action Reminder

September 19, 2023 | benzinga.com

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors

September 27, 2023 | Edge On The Street (Ad)

Is Gold Really Boring?

September 19, 2023 | businesswire.com

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors

September 15, 2023 | benzinga.com

Orthofix Medical Director Trades $101K In Company Stock

September 15, 2023 | benzinga.com

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors

September 15, 2023 | finance.yahoo.com

Director James Hinrichs Acquires 7,500 Shares of Orthofix Medical Inc

September 15, 2023 | businesswire.com

ORTHOFIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Orthofix Medical Inc. on Behalf of Orthofix Stockholders and Encourages Investors to Contact the Firm

September 14, 2023 | technews.tmcnet.com

The Law Offices of Frank R. Cruz Continues Its Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors

September 13, 2023 | benzinga.com

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Orthofix Medical Inc. - OFIX

September 13, 2023 | technews.tmcnet.com

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors

September 13, 2023 | marketwatch.com

Orthofix’s stock has worst day in nearly 30 years after 3 top executives are fired for ‘offensive conduct’

September 13, 2023 | benzinga.com

Ademi LLP Investigates Claims of Securities Fraud against Orthofix Medical Inc.

September 13, 2023 | msn.com

BTIG Downgrades Orthofix Medical (OFIX)

September 13, 2023 | benzinga.com

The Law Offices of Frank R. Cruz Announces Investigation of Orthofix Medical Inc. (OFIX) on Behalf of Investors

September 12, 2023 | markets.businessinsider.com

JMP Securities Sticks to Their Hold Rating for Orthofix (OFIX)

September 12, 2023 | benzinga.com

Investigation of Orthofix Medical Inc. (OFIX) Announced by Holzer & Holzer, LLC

September 12, 2023 | msn.com

Orthofix (NASDAQ: OFIX) Plummets After Leadership Changes

September 12, 2023 | marketwatch.com

Orthofix Medical Shares Drop About 16% After Board Ousts Top Executives

September 12, 2023 | marketwatch.com

Orthofix terminates CEO, CFO and CLO for ‘repeated inappropriate and offensive conduct’

September 12, 2023 | markets.businessinsider.com

Orthofix Medical Names Catherine Burzik Interim CEO; Appoints Geoffrey Gillespie As Interim CFO

See More Headlines

Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

OFIX Company Calendar

Last Earnings: 8/08/2023
Today: 9/27/2023
Next Earnings (Estimated): 11/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: Health Care Equipment
Sector: Medical
Current Symbol: NASDAQ:OFIX
CUSIP: N6748L10
CIK: 884624
Web: www.orthofix.com
Phone: (214) 937-2000
Fax: 599 9 461 6978
Employees: 1,092
Year Founded: 1980

Price Target and Rating

Average Stock Price Forecast: $16.00
High Stock Price Forecast: $16.00
Low Stock Price Forecast: $16.00
Forecasted Upside/Downside: +29.0%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.66)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-19,750,000.00
Net Margins: -19.74%
Pretax Margin: -19.15%
Return on Equity: -1.90%
Return on Assets: -1.38%

Debt

Debt-to-Equity Ratio: 0.11
Current Ratio: 2.82
Quick Ratio: 1.25

Sales & Book Value

Annual Sales: $460.71 million
Price / Sales: 0.99
Cash Flow: $1.87 per share
Price / Cash Flow: 6.62
Book Value: $16.71 per share
Price / Book: 0.74

Miscellaneous

Outstanding Shares: 36,740,000
Free Float: 35,012,000
Market Cap: $455.58 million
Optionable: Optionable
Beta: 0.85

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Ms. Catherine M. Burzik M.A. (Age 73)
MA, Interim CEO & Chair of the Board
Comp: $137.5k

Ms. Kimberley A. Elting (Age 58)
Pres of Global Orthopedics
Comp: $766.67k

Mr. Kevin J. Kenny (Age 58)
Pres of Global Spine Bus.
Comp: $607.64k

Mr. Geoffrey C. Gillespie
VP, Corp. Controller & Interim CFO

Mr. Roberto Donadello
Sr. VP of Global Operations

Dr. Frank Vizesi Ph.D.
Chief Scientific Officer

Mr. Dan E. Yarbrough
VP of Investor Relations

Ms. Puja Leekha
Sr. VP, Chief Ethics & Compliance Officer and Interim Chief Legal Officer

Ms. Suzanne Armstrong
Chief HR Officer

Mr. Ehab M. Esmail (Age 51)
Sr. VP of Global Quality, Regulatory & Clinical Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

OFIX Stock - Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OFIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares.
View OFIX analyst ratings or view top-rated stocks.
What is Orthofix Medical's stock price forecast for 2023?: 2 brokerages have issued 12 month price targets for Orthofix Medical's shares. Their OFIX share price forecasts range from $16.00 to $16.00. On average, they predict the company's share price to reach $16.00 in the next twelve months. This suggests a possible upside of 29.0% from the stock's current price.
View analysts price targets for OFIX or view top-rated stocks among Wall Street analysts.
How have OFIX shares performed in 2023?: Orthofix Medical's stock was trading at $20.53 at the beginning of 2023. Since then, OFIX stock has decreased by 39.6% and is now trading at $12.40.
View the best growth stocks for 2023 here.
When is Orthofix Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our OFIX earnings forecast.
How were Orthofix Medical's earnings last quarter?: Orthofix Medical Inc. (NASDAQ:OFIX) announced its earnings results on Tuesday, August, 8th. The medical device company reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.67) by $0.69. The medical device company had revenue of $187.02 million for the quarter, compared to the consensus estimate of $183.80 million. Orthofix Medical had a negative net margin of 19.74% and a negative trailing twelve-month return on equity of 1.90%.
What ETF holds Orthofix Medical's stock ?: Syntax Stratified SmallCap ETF holds 3,764 shares of OFIX stock, representing 0.39% of its portfolio.
What guidance has Orthofix Medical issued on next quarter's earnings?: Orthofix Medical issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $752.00 million-$758.00 million, compared to the consensus revenue estimate of $750.57 million.
What is Brad Mason's approval rating as Orthofix Medical's CEO?: 32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Orthofix Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).
What is Orthofix Medical's stock symbol?: Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."
Who are Orthofix Medical's major shareholders?: Orthofix Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.30%), Rubric Capital Management LP (6.55%), Segall Bryant & Hamill LLC (5.65%), State Street Corp (4.33%), Dimensional Fund Advisors LP (3.23%) and Paradice Investment Management LLC (2.58%). Insiders that own company stock include Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kevin J Kenny, Kimberley A Elting, Michael E Paolucci, Rice Doug and Shweta Maniar.
View institutional ownership trends.
How do I buy shares of Orthofix Medical?: Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Orthofix Medical's stock price today?: One share of OFIX stock can currently be purchased for approximately $12.40.
How much money does Orthofix Medical make?: Orthofix Medical (NASDAQ:OFIX) has a market capitalization of $455.58 million and generates $460.71 million in revenue each year. The medical device company earns $-19,750,000.00 in net income (profit) each year or ($3.66) on an earnings per share basis.
How many employees does Orthofix Medical have?: The company employs 1,092 workers across the globe.
How can I contact Orthofix Medical?: Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The official website for the company is www.orthofix.com. The medical device company can be reached via phone at (214) 937-2000, via email at markquick@orthofix.com, or via fax at 599 9 461 6978.

This page (NASDAQ:OFIX) was last updated on 9/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Orthofix Medical (OFIX) Stock Forecast, Price & News

Orthofix Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About Orthofix Medical (NASDAQ:OFIX) Stock

OFIX Price History

OFIX Stock News Headlines

OFIX Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

OFIX Stock - Frequently Asked Questions

Overall MarketRank^™